Pfizer asks FDA to grant emergency use authorization for COVID-19 vaccine in kids aged 5 to 11

Pfizer on Thursday formally applied for Emergency Use Authorization (EUA) with the Food and Drug Administration for a smaller dose of its COVID-19 vaccine for use in children aged between 5 and 11.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting